ACAD Q3 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue GrowthZacks Investment Research • 11/06/25
Acadia Pharmaceuticals (ACAD) Q3 Earnings and Revenues Top EstimatesZacks Investment Research • 11/05/25
Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating OverviewBusiness Wire • 11/05/25
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/29/25
Does Acadia (ACAD) Have the Potential to Rally 27.66% as Wall Street Analysts Expect?Zacks Investment Research • 10/28/25
Halper Sadeh LLC Encourages Acadia Pharmaceuticals Inc. Shareholders to Contact the Firm to Discuss Their RightsBusiness Wire • 10/22/25
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025Business Wire • 10/15/25
Acadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson's Disease and Movement Disorders®Business Wire • 10/02/25
ACAD Stock Down 10% Following Phase III Hyperphagia Study FailureZacks Investment Research • 09/25/25
Acadia Pharma Tumbles On Failed Appetite Suppressant; Soleno SurgesInvestors Business Daily • 09/24/25
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary EndpointBusiness Wire • 09/24/25
Real World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Developmental Medicine and Child NeurologyBusiness Wire • 09/12/25
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 09/08/25
ACADIA Pharmaceuticals Inc. (ACAD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/08/25
Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy OfficerBusiness Wire • 08/25/25
Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue GrowthZacks Investment Research • 08/07/25
Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/06/25